Loading clinical trials...

DERCOS DS DANDRUFF TREATMENT OBSERVATIONAL STUDY 2022 | Clinical Trials | Clareo Health

COMPLETED

DERCOS DS DANDRUFF TREATMENT OBSERVATIONAL STUDY 2022

NCT05989633•Cosmetique Active International

View on ClinicalTrials.gov

Summary

The aim of this study is to evaluate the satisfaction / tolerance / cosmeticity of Dercos DS

Eligibility

Age

12 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients with dandruff or seborrheic dermatitis
•All hair types
•All ethnicities (Asian, Caucasian, Afro-American, African, Hispanic)
•Including patients with specific occlusion habits (for instance veil use at least 8 hours per day, hat use)
•Patients willing to provide written informed consent

Exclusion Criteria

•Under 12 years old
•Pregnancy, breast feeding, childbearing potential without adequate contraception, or irregular menstrual cycles.
•History of allergy, anaphylaxis or hypersensitivity to any of the ingredients of Shampoo any of the ingredients of DERCOS ANTI-DANDRUFF normal to oily hair shampoo
•History of allergic contact dermatitis secondary to shampoo, conditioner, mask, and/or leave-in.
•Has any clinical manifestations in the treatment(s) or other disorders that, in the opinion of the investigator, may affect the evaluations or results of the study products.- Inability to stay the study period (56 days +-5 days) without performing any hair/scalp procedure, including coloring, straightening and cutting.
•Inability to attend all study visits and follow treatment regimen

Locations (1)

Marta Sar Pormian

Warsaw, Poland

Key Dates

Start Date

July 4, 2022

Primary Completion Date

June 29, 2023

Completion Date

June 29, 2023

Last Updated

August 14, 2023

Enrollment

5,131

ACTUAL participants

Conditions

Dandruff

Interventions

Dermocosmetic product: Selenium Disluphide Shampoo (Dercos DS)

OTHER

Antidandruff Lotion Mediating Microbiome Rebalance

NCT06813521

Dandruff

View study

SUSPENDEDNA

Cleansing Device for the Treatment of Scalp and Hair Conditions

NCT05319444

DandruffSeborrheic Dermatitis+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 14, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions